Neo Ivy Capital Management - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$375
-99.6%
15,099
+189.9%
0.20%
+70.7%
Q3 2021$101,000
-66.2%
5,209
-32.4%
0.12%
-61.6%
Q2 2021$299,000
+199.0%
7,704
+272.4%
0.30%
+174.5%
Q1 2021$100,000
-22.5%
2,069
-16.8%
0.11%
-23.6%
Q4 2020$129,000
-7.2%
2,487
-52.2%
0.14%
+2.1%
Q3 2020$139,000
+37.6%
5,208
-0.0%
0.14%
+271.1%
Q2 2020$101,0005,2090.04%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders